Drug and vaccine authorizations for COVID-19: List of authorized drugs, vaccines and expanded indications

Date published: 2021-05-05

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.

In the list below, the entry for each authorized drug and vaccine includes the:

In the "authorization" column, there are 4 possible scenarios for each drug or vaccine:

List of authorized drugs, vaccines and expanded indications for COVID-19
Authorization holder Brand name, proper name or common name Therapeutic area Control number Date of authorization or expanded indication Authorization or expanded indication
BioNTech Manufacturing GmbH Pfizer-BioNTech COVID-19 Vaccine Tozinameran (mRNA vaccine, BNT162b2) suspension for injection Vaccines, for human use 251730 2021-05-05

Pediatric indication (ages 12-15).

Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.

BioNTech Manufacturing GmbH Pfizer-BioNTech COVID-19 Vaccine
Tozinameran (mRNA vaccine, BNT162b2) suspension for injection
Vaccines, for human use 244906 2020-12-09 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Gilead Sciences Canada Inc. Veklury
Remdesivir solution for injection
Antivirals for systemic use, for human use 240551 2020-07-27 Food and Drug Regulations. Issued Notice of Compliance under the NOC/c Guidance.
Eli Lilly Canada Inc Bamlanivimab
Bamlanivimab solution for injection
Immune sera and immunoglobulins, for human use 244947 2020-11-20 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Moderna Therapeutics Inc COVID-19 Vaccine Moderna
mRNA-1273 SARS-CoV-2
suspension for injection
Vaccines, for human use 244946 2020-12-23 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
AstraZeneca Canada Inc AstraZeneca COVID-19 Vaccine
ChAdOx1-S (recombinant)
solution for injection
Vaccines, for human use 244627 2021-02-26 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Covishield
ChAdOx1-S (recombinant)
solution for injection
Vaccines, for human use 248651 2021-02-26 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Janssen Inc Janssen COVID-19 Vaccine
AD26.COV2.S (recombinant)
suspension for injection
Vaccines, for human use 246758 2021-03-05 Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: